Works matching IS 13518216 AND DT 2023 AND VI 29 AND IP 4

Results: 28

Development of inhibitors in women with mild haemophilia A and concurrent treatment with immune tolerance therapy and emicizumab.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1167, doi. 10.1111/hae.14821

By:

Cheong, May Anne;
Ang, Jun Yang;
Yeam, Shim Yen;
Ng, Heng Joo;
Tien, Sim Leng

Publication type:

Article

Real‐world data for the use of emicizumab in haemophilia A patients with inhibitors – First nationwide report from Korea.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1163, doi. 10.1111/hae.14819

By:

Hahn, Seung Min;
Han, Jung Woo;
Kim, Jin Seok;
Shim, Ye Jee;
Kim, Soyon;
Kim, Hugh Chul;
Park, Young Shil;
Lyu, Chuhl Joo

Publication type:

Article

Matching‐adjusted indirect comparison of bleeding outcomes in severe haemophilia A: Comparing valoctocogene roxaparvovec gene therapy, emicizumab prophylaxis, and FVIII replacement prophylaxis.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1087, doi. 10.1111/hae.14818

By:

Astermark, Jan;
Buckner, Tyler W;
Frenzel, Laurent;
Hatswell, Anthony J;
You, Xiaojun;
Liu, Hai;
Goodman, Erin;
Santos, Sandra;
Hawes, Charles;
Hinds, David;
Klamroth, Robert

Publication type:

Article

Mild FVII deficiency – Correlation between genotype and phenotype.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1160, doi. 10.1111/hae.14817

By:

Fraser, Craig;
Watson, Henry G.;
Khan, Mohammed M.

Publication type:

Article

Clinical, neuroimaging, and behavioural risk factors for neurocognitive impairment in Chinese patients with haemophilia: A multicentre study.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1074, doi. 10.1111/hae.14816

By:

Cheung, Yin Ting;
Ma, Chung Tin;
Lam, Henry Hon Wai;
Ling, Siu Cheung;
Kwok, Kevin;
Li, Chak Ho;
Ha, Chung Yin;
Yip, Sze Fai;
Wong, Raymond Siu Ming;
Chu, Winnie Chiu Wing;
Li, Chi Kong

Publication type:

Article

Design, development and usability of an educational AI chatbot for People with Haemophilia in Senegal.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1063, doi. 10.1111/hae.14815

By:

Babington‐Ashaye, Awa;
de Moerloose, Philippe;
Diop, Saliou;
Geissbuhler, Antoine

Publication type:

Article

Safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of marstacimab in Chinese participants with severe haemophilia.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1155, doi. 10.1111/hae.14814

By:

Sun, Xiaohong;
Liu, Wei;
Luo, Binyu;
Ma, Dongwei;
Kalluru, Hindu;
Zhou, Yangmei;
Li, Jin;
Peng, Ao;
Liu, Yuwang;
Tong, Xin;
Sun, Lei;
Teeter, John;
Raje, Sangeeta;
Yang, Renchi

Publication type:

Article

Longitudinal observations of TFPI levels in paediatric Haemophilia A patients.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1142, doi. 10.1111/hae.14813

By:

Schwers, Stephan;
Shah, Anita;
Linardi, Camila;
Zhang, Yang;
Willmann, Stefan

Publication type:

Article

Haemophilia joint health score (HJHS) usage, patterns and outcome data in patients with haemophilia A and haemophilia B in Australia: A descriptive study using the Australian Bleeding Disorders Registry (ABDR).

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1135, doi. 10.1111/hae.14812

By:

George, Carly;
Parikh, Sumit;
Carter, Tina;
Morris, Alison;
Cramey, Cameron;
Mcelroy, Kymberley;
Tran, Huyen

Publication type:

Article

HRQoL and psychosocial aspects of burden on caregivers to children with moderate or severe von Willebrand disease.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1056, doi. 10.1111/hae.14811

By:

Olsson, Anna;
Petrini, Pia;
Engman Grahn, Emma;
Myrin Westesson, Linda

Publication type:

Article

Reported prevalence of von Willebrand disease worldwide in relation to income classification.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 975, doi. 10.1111/hae.14810

By:

Stonebraker, Jeffrey S.;
Iorio, Alfonso;
Lavin, Michelle;
Rezende, Suely M.;
Srivastava, Alok;
Pierce, Glenn F.;
Coffin, Donna;
Tootoonchian, Ellia;
Makris, Michael

Publication type:

Article

Emicizumab for acquired haemophilia A: A case series.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1049, doi. 10.1111/hae.14809

By:

Engelen, Matthias M.;
Vandesande, Johan;
De Bent, Johan;
Van Laer, Christine;
Labarque, Veerle;
Jacquemin, Marc;
Peerlinck, Kathelijne;
Hermans, Cedric;
Verhamme, Peter;
Vanassche, Thomas

Publication type:

Article

No immunological changes after factor VIII product switch: An in depth analysis in haemophilia A patients.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1039, doi. 10.1111/hae.14808

By:

Schep, Sarah J.;
Fischer, Kathelijn;
Boes, Marianne;
Schutgens, Roger E. G.

Publication type:

Article

Towards achieving a haemophilia‐free mind.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 951, doi. 10.1111/hae.14807

By:

Hermans, Cedric;
Pierce, Glenn F.

Publication type:

Article

Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health‐related quality of life in patients with severe haemophilia A.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1032, doi. 10.1111/hae.14806

By:

Arvanitakis, Alexandros;
Holme, Pål Andre;
Berntorp, Erik;
Astermark, Jan

Publication type:

Article

Acceptability of prenatal diagnosis and prenatal treatment of haemophilia using cell and gene therapies within US haemophilia community.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1024, doi. 10.1111/hae.14805

By:

Pham, Quan D. M.;
Thomson, Sharon M.;
Schaible, Burk N.;
Mills, Kevin D.;
Atala, Anthony;
Porada, Christopher D.;
Almeida‐Porada, Graça

Publication type:

Article

Von Willebrand Disease: Gaining a global perspective.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1104, doi. 10.1111/hae.14804

By:

O'Sullivan, Jamie M.;
Tootoonchian, Ellia;
Ziemele, Baiba;
Makris, Michael;
Federici, Augusto B.;
Khayat Djambas, Claudia;
El Ekiaby, Magdy;
Rotellini, Dawn;
Sidonio, Robert F.;
Iorio, Alfonso;
Coffin, Donna;
Pierce, Glenn F.;
Stonebraker, Jeffrey;
James, Paula D.;
Lavin, Michelle

Publication type:

Article

Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 954, doi. 10.1111/hae.14803

By:

Mannucci, Pier Mannuccio;
Kessler, Craig M.;
Germini, Federico;
Nissen, Francis;
Ofori‐Asenso, Richard;
Brocchieri, Cristian;
Bendinelli, Sara;
Iorio, Alfonso

Publication type:

Article

A focus on dominant negative variants in a series of 170 heterozygous FXI‐deficient patients.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1113, doi. 10.1111/hae.14802

By:

de Mazancourt, Philippe;
Quélin, Florence;
Flaujac, Claire;
de Raucourt, Emmanuelle;
Guillet, Benoît;
Bauduer, Frédéric;
Ernest, Vincent;
Beurrier, Philippe;
Avril, Aurélie;
d'Oiron, Roseline;
Biron‐Andréani, Christine;
Meunier, Sandrine;
Dargaud, Yesim

Publication type:

Article

Desmopressin (DDAVP) use in patients with von Willebrand disease: A single‐centre retrospective review of test response and clinical outcomes.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1095, doi. 10.1111/hae.14801

By:

Chandrakumaran, Priya;
Hews‐Girard, Julia;
Poon, Man‐Chiu

Publication type:

Article

Clotting factor activity levels and bleeding risk in people with haemophilia playing sports.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1013, doi. 10.1111/hae.14800

By:

Versloot, Olav;
Kemler, Ellen;
Blokzijl, Johan;
Timmer, Merel;
Schuuring, Marleen;
van Galen, Karin P. M.;
Kremer Hovinga, Idske Cornelia L.;
van der Valk, Paul R.;
van Vulpen, Lize F. D.;
Schutgens, Roger E. G.;
van Koppenhagen, Casper F.;
van der Net, Janjaap;
Fischer, Kathelijn

Publication type:

Article

Tandem and inverted duplications in haemophilia A: Breakpoint characterisation provides insight into possible rearrangement mechanisms.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1121, doi. 10.1111/hae.14799

By:

Li, Yang;
Ding, Biying;
Mao, Yinqi;
Zhang, Huayang;
Wang, Xuefeng;
Ding, Qiulan

Publication type:

Article

Clinical features and laboratory diagnostic issues of non‐immune, non‐amyloid related acquired factor X deficiency.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1150, doi. 10.1111/hae.14798

By:

Ichinose, Akitada;
Osaki, Tsukasa;
Souri, Masayoshi

Publication type:

Article

Real‐world evidence on efmoroctocog alfa in patients with haemophilia A: A systematic literature review of treatment experience in Europe.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 963, doi. 10.1111/hae.14797

By:

Blatný, Jan;
Nielsen, Emma Munk;
Reitzel, Signe Baattrup;
McMillan, Annabell Cajus;
Danø, Anne;
Bystrická, Linda;
Kragh, Nana;
Klamroth, Robert

Publication type:

Article

Long‐term immunogenicity, efficacy and tolerability of simoctocog alfa in patients with severe haemophilia A who had completed the NuProtect study in previously untreated patients.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 1005, doi. 10.1111/hae.14796

By:

Mathias, Mary;
Abashidze, Marina;
Abraham, Aby;
Belletrutti, Mark J.;
Carcao, Manuel;
Chambost, Hervé;
Chan, Anthony K. C.;
Dubey, Leonid;
Ducore, Jonathan;
Lambert, Thierry;
Kavardakova, Natalya;
Lohade, Sunil;
Turea, Valentin;
Wu, John K. M.;
Klukowska, Anna

Publication type:

Article

Efficacy and safety of the B‐domain‐deleted TQG202 for on‐demand treatment in moderate and severe haemophilia A patients: A multicentre, single‐arm trial.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 997, doi. 10.1111/hae.14777

By:

Sun, Zimin;
Xi, Yaming;
Liu, Wei;
Yang, Linhua;
Wang, Xuefeng;
Jin, Chenghao;
Jia, Haifei;
Zhang, Lei

Publication type:

Article

No difference in quality of life between persons with severe haemophilia A and B.

Published in:

Haemophilia, 2023, v. 29, n. 4, p. 987, doi. 10.1111/hae.14759

By:

Kihlberg, Kristina;
Baghaei, Fariba;
Bruzelius, Maria;
Funding, Eva;
Andre Holme, Pål;
Lassila, Riitta;
Nummi, Vuokko;
Ranta, Susanna;
Gretenkort Andersson, Nadine;
Berntorp, Erik;
Astermark, Jan

Publication type:

Article

Issue Information.

Published in:: Haemophilia, 2023, v. 29, n. 4, p. 947, doi. 10.1111/hae.14599
Publication type:: Article